Zachry Acquires Ambitech Engineering

(c) Lichtmeister/Shutterstock
(c) Lichtmeister/Shutterstock

US engineering and construction group Zachry has acquired rival firm Ambitech Engineering for an undisclosed sum. Zachry said the acquisition adds extensive resources, capabilities and market reach.

Ambitech, headquartered in Chicago, Illinois, has 750 employees in multiple locations across the US as well as in India, the Philippines and the Middle East. Its primary industry sectors include refining, petrochemicals, food and beverage, pharmaceuticals, biotechnology and consumer products.

John Zachry, chairman and CEO of Zachry, said the company is always looking for opportunities to grow and improve its capabilities. “To acquire a high-performing and well-regarded company will be a game-changer for us,” he said, adding that the Ambitech team further enhances Zachry’s ability to provide full-service support to its principal businesses across North America, including engineering, construction, maintenance, turnarounds and specialty services.

Headquartered in San Antonio, Texas, Zachry operates 35 offices with over 22,000 employees working in more than 400 locations across North America. The company has worked with major petrochemical companies such as BASF, Ineos, ExxonMobil, Chevron Phillips Chemical, among others.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.